6.880
+7,00%
2026-10-19
Fundamental Analysis
26 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -138.1% | -30.6% | 2 / 3 | -37.3% | -29.68 pp | -34.80 pp | +4.3% | 0.61 | 13.57 | 10,3 | −37,3% | −1,4 | −138,1% | 13.57 | 12.33 | +10,1% |
| Pts | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 6.880 (close price on 2026-10-19)EPS (TTM): 507,0
Financial charts
1.Revenue & growth
VND bn10,3Q2/26
1.Revenue & growth
VND bn10,3Q2/26
2.Profit & growth
VND bn-1,35Q2/26
3.Profit mix (Penman)
VND bn24,7Q2/26
4.Margins & cost structure
%52.8%Q2/26
5.Returns & cash cycle
% · days4.2%Q2/26
6.Earnings quality & cash
VND bn32,4Q2/26
7.Asset structure
VND bn383Q2/26
8.Funding & debt health
VND bn · times383Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %13,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-66Q2/26
Adjusted EPS growth, latest quarter
-138%
Average adjusted EPS growth, 3 quarters
-60.6%
averaged over 2 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26